Two Alberta children are the first in North America to use the Berlin Heart EXCOR Active, opening up the future possibility for kids to stay home while awaiting a heart transplant.
Lead author Dr. Naveed Janjua said the findings related to second doses for both vaccines show men between the ages of 18 and 29 are most at risk of myocarditis if they received Moderna's COVID-19 vaccine.